Insider · CIK 0001225149

SCHREIBER ALAIN

Reports to the SEC for 10 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001225149

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-01-04	EAGLE PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	10% Owner	AAward	+15K sh	—	—	15,000
2015-04-21	EAGLE PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	10% Owner	AAward	+10K sh	—	—	10,000
2015-03-13	EAGLE PHARMACEUTICALS, INC.Option (right to buy)A Award	10% Owner	AAward	+5,000 sh	—	—	5,000
2014-02-18	EAGLE PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+1.93M sh	—	—	1,966,987
2014-02-18	EAGLE PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+1.03M sh	—	—	2,995,600
2014-02-18	EAGLE PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+851K sh	—	—	3,846,120
2014-02-18	EAGLE PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+570K sh	—	—	4,415,658
2014-02-18	EAGLE PHARMACEUTICALS, INC.X Exercise of In-Money	10% Owner	XExercise of In-Money	+21.8K sh	—	—	4,437,495
2014-02-18	EAGLE PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+333K sh	$15.00	+$5M	4,770,828
2014-02-18	EAGLE PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+62.6K sh	—	—	62,575
2014-02-18	EAGLE PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+9,359 sh	—	—	71,934
2014-02-18	EAGLE PHARMACEUTICALS, INC.X Exercise of In-Money	10% Owner	XExercise of In-Money	+357 sh	—	—	72,291
2014-02-18	EAGLE PHARMACEUTICALS, INC.Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.93M sh	—	—	0
2014-02-18	EAGLE PHARMACEUTICALS, INC.Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.03M sh	—	—	0
2014-02-18	EAGLE PHARMACEUTICALS, INC.Series B-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−851K sh	—	—	0
2014-02-18	EAGLE PHARMACEUTICALS, INC.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−570K sh	—	—	0
2014-02-18	EAGLE PHARMACEUTICALS, INC.Series C WarrantsX Exercise of In-Money	10% Owner	XExercise of In-Money	−98.4K sh	—	—	0
2014-02-18	EAGLE PHARMACEUTICALS, INC.Series B-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−62.6K sh	—	—	0
2014-02-18	EAGLE PHARMACEUTICALS, INC.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−9,359 sh	—	—	0
2014-02-18	EAGLE PHARMACEUTICALS, INC.Series C WarrantsX Exercise of In-Money	10% Owner	XExercise of In-Money	−1,614 sh	—	—	0
2010-01-08	OPTIMER PHARMACEUTICALS INCStock option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2009-03-04	OPTIMER PHARMACEUTICALS INCP Purchase	Director	PPurchase	+176K sh	—	—	1,450,973
2009-03-04	OPTIMER PHARMACEUTICALS INCP Purchase	Director	PPurchase	+7,450 sh	—	—	61,556
2009-03-04	OPTIMER PHARMACEUTICALS INCP Purchase	Director	PPurchase	+91.5K sh	—	—	405,998
2009-03-04	OPTIMER PHARMACEUTICALS INCP Purchase	Director	PPurchase	+183K sh	—	—	811,998
2009-03-04	OPTIMER PHARMACEUTICALS INCWarrants to purchase common stockP Purchase	Director	PPurchase	+35.1K sh	—	—	35,123
2009-03-04	OPTIMER PHARMACEUTICALS INCWarrants to purchase common stockP Purchase	Director	PPurchase	+1,490 sh	—	—	1,490
2009-03-04	OPTIMER PHARMACEUTICALS INCWarrants to purchase common stockP Purchase	Director	PPurchase	+18.3K sh	—	—	18,307
2009-03-04	OPTIMER PHARMACEUTICALS INCWarrants to purchase common stockP Purchase	Director	PPurchase	+36.6K sh	—	—	36,613
2009-01-08	OPTIMER PHARMACEUTICALS INCStock option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2007-09-12	OPTIMER PHARMACEUTICALS INCA Award	Director	AAward	+2,500 sh	—	—	2,500

Recent filings

Accepted (ET)
Jan 54
EAGLE PHARMACEUTICALS, INC.0001209191-16-088799
SEC(opens sec.gov)
Apr 224
EAGLE PHARMACEUTICALS, INC.0001209191-15-035550
SEC(opens sec.gov)
Mar 184
EAGLE PHARMACEUTICALS, INC.0001209191-15-027321
SEC(opens sec.gov)
Feb 204
EAGLE PHARMACEUTICALS, INC.0001209191-14-012766
SEC(opens sec.gov)

Companies

Address

90 NASSAU STREET 5TH FLOOR

PRINCETON, NJ, 08542